Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Shruti Saxena-Beem"'
Autor:
Sunah Kang, Megan EB Clowse, Saira Z Sheikh, Jennifer L Rogers, Karissa Grier, Barbara Vilen, Liubov Arbeeva, Shruti Saxena-Beem, Anthony Trujillo
Publikováno v:
Lupus Science and Medicine, Vol 11, Iss Suppl 2 (2024)
Externí odkaz:
https://doaj.org/article/d6ddd70972ee4893a4a277b4b21acc45
Autor:
Shruti Saxena‐Beem, Teresa A. Dickson, Tessa R. Englund, Rebecca J. Cleveland, Emily M. McCormick, Andres E. Santana, Julie A. Walker, Kelli D. Allen, Saira Z. Sheikh
Publikováno v:
ACR Open Rheumatology, Vol 4, Iss 12, Pp 1042-1049 (2022)
Objective The objective of this cross‐sectional study was to investigate the impact of the COVID‐19 pandemic on physical activity (PA) levels of patients with rheumatic and musculoskeletal diseases (RMDs) and to examine factors associated with de
Externí odkaz:
https://doaj.org/article/f580e489602340fbb8e010c3c2c23da8
Autor:
Rumey C. Ishizawar, Kunal Patel, M. Patricia Rivera, Shruti Saxena-Beem, Todd A. Schwartz, William T. Atchley, Carolina Alvarez
Publikováno v:
Chest. 160:731-742
Background Immune checkpoint inhibitors (ICIs) are standard treatments for advanced non-small cell lung cancer and have expanded use in small cell lung cancer. Although generally better tolerated than traditional chemotherapy, immune-related adverse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c25b1db6bdb332467ef35c0d5eff848
https://doi.org/10.1016/j.chest.2021.02.032
https://doi.org/10.1016/j.chest.2021.02.032
Publikováno v:
BMC rheumatology. 6(1)
Introduction Immune checkpoint inhibitors (ICIs) enhance the immune system’s ability to target and destroy cancer cells, but this non-specific immune overactivation can result in immune-related adverse events (irAEs). Patients with underlying autoi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d49af7dee60af21d6da9798a5bcbc99c
https://pubmed.ncbi.nlm.nih.gov/36345032
https://pubmed.ncbi.nlm.nih.gov/36345032
Autor:
Håkan Wallén, Andrea L. Johnstone, Saira Z Sheikh, Denis F. Noubouossie, Katherina Aguilera, Maja Månsson, Matthew R. Marunde, Charlotte Thålin, Matthew J. Meiners, Sarah A. Howard, Maud Daleskog, Martis W. Cowles, Zu-Wen Sun, Staffan Lundström, Jonathan M. Burg, Michael-Christopher Keogh, Axel Rosell, Nathan W. Hall, Marcus A. Cheek, Matthew F. Whelihan, Yohei Hisada, Nigel Mackman, Nigel S. Key, Shruti Saxena-Beem
Publikováno v:
Journal of thrombosis and haemostasis : JTH
Background Recent data propose a diagnostic and prognostic capacity for citrullinated histone H3 (H3Cit), a marker of neutrophil extracellular traps (NETs), in pathologic conditions such as cancer and thrombosis. However, current research is hampered
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ae90fd748dbb220c9c7c6d7ca84b038
https://doi.org/10.1111/jth.15003
https://doi.org/10.1111/jth.15003
Autor:
William T. Atchley, Carolina Alvarez, Shruti Saxena-Beem, Todd A. Schwartz, Rumey C. Ishizawar, Kunal P. Patel, M. Patricia Rivera
Publikováno v:
Chest. 161(3)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7270fcabc19927f0c52cc9f0cbc2ddcd
https://pubmed.ncbi.nlm.nih.gov/35256099
https://pubmed.ncbi.nlm.nih.gov/35256099
Publikováno v:
Journal of the Endocrine Society. 6:A554-A554
Background/Purpose Hypophysitis is a known complication of immune checkpoint inhibitor (ICI) therapies used in the treatment of malignant cancers. In general, central adrenal insufficiency (AI) and hypothyroidism are the most recognized deficiencies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::029616fa787308a54a641c939a2524ab
https://doi.org/10.1210/jendso/bvac150.1151
https://doi.org/10.1210/jendso/bvac150.1151
Autor:
Francis J. Keefe, Kim L Bennell, Kimberlea Grimm, Saira Z Sheikh, Andres Santana, Rebecca J. Cleveland, Kelli D. Allen, Katie Huffman, Tyler Beauchamp, Shruti Saxena Beem, Julie Walker, David G Hu, Christine Rini
Publikováno v:
BMC Rheumatology
BMC Rheumatology, Vol 5, Iss 1, Pp 1-10 (2021)
BMC Rheumatology, Vol 5, Iss 1, Pp 1-10 (2021)
Background Patients with Systemic Lupus Erythematosus (SLE) often experience pain and other symptoms that negatively impact quality of life. Interventions that enhance the use of behavioral and cognitive coping strategies may lead to improved outcome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::163dc9ceb168e6a93e56fea04ea62de5
http://europepmc.org/articles/PMC8210367
http://europepmc.org/articles/PMC8210367
Autor:
William T, Atchley, Carolina, Alvarez, Shruti, Saxena-Beem, Todd A, Schwartz, Rumey C, Ishizawar, Kunal P, Patel, M Patricia, Rivera
Publikováno v:
Chest
BACKGROUND: Immune checkpoint inhibitors (ICIs) are standard treatments for advanced non-small cell lung cancer and have expanded use in small cell lung cancer. Although generally better tolerated than traditional chemotherapy, immune-related adverse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::bc5253b83f55a741ca709a8d68d24bb5
https://europepmc.org/articles/PMC8411447/
https://europepmc.org/articles/PMC8411447/
Publikováno v:
Lupus (Los Angeles)
Objective: Annual influenza and pneumococcal vaccination rates remain suboptimal in patients with systemic lupus erythematosus despite their higher risk of infections and related complications. The CDC identified lack of knowledge about vaccine guide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::406f1188bfe72341a87ed29bef1cb828
https://pubmed.ncbi.nlm.nih.gov/32051964
https://pubmed.ncbi.nlm.nih.gov/32051964